All Stories

  1. Correction: Andrei et al. Competitive Fitness of Cytomegalovirus Mutants Bearing Changes in the UL56 Terminase Subunit, Associated with Letermovir-Resistance, in Presence and Absence of Antivirals. Viruses 2026, 18, 779

    Article • Viruses, August 2026, MDPI AG

    Sarah Gillemot

  2. Competitive Fitness of Cytomegalovirus Mutants Bearing Changes in the UL56 Terminase Subunit, Associated with Letermovir-Resistance, in Presence and Absence of Antivirals

    Article • Viruses, July 2026, MDPI AG

    Sarah Gillemot

  3. Emergence of Antiviral Drug Resistance in Congenital Cytomegalovirus Infection During Treatment: An Updated Review of Literature and Case Report

    Article • The Pediatric Infectious Disease Journal, August 2025, Wolters Kluwer Health

    Sarah Gillemot

  4. Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient

    Article • Journal of Antimicrobial Chemotherapy, July 2025, Oxford University Press (OUP)

    Sarah Gillemot

  5. Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase

    Article • Viruses, July 2025, MDPI AG

    Sarah Gillemot

  6. Cytomegalovirus infection and drug resistance emergence during letermovir salvage therapy in a pediatric SCID patient

    Article • npj Antimicrobials and Resistance, May 2025, Springer Science + Business Media

    Sarah Gillemot

  7. Congenital cytomegalovirus infection despite valaciclovir secondary prevention: should we fear antiviral resistance?

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, December 2024, Elsevier

    Sarah Gillemot

  8. Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan Donor

    Article • Transplantation, September 2024, Wolters Kluwer Health

    Sarah Gillemot

  9. A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing

    Article • The Journal of Infectious Diseases, May 2023, Oxford University Press (OUP)

    Sarah Gillemot

  10. Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase

    Article • Journal of Antimicrobial Chemotherapy, September 2022, Oxford University Press (OUP)

    Sarah Gillemot

  11. An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness

    Article • Viruses, May 2021, MDPI AG

    Sarah Gillemot

  12. Viral fitness of MHV-68 viruses harboring drug resistance mutations in the protein kinase or thymidine kinase

    Article • Antiviral Research, October 2020, Elsevier

    Sarah Gillemot

  13. Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss

    Article • Antiviral Research, August 2019, Elsevier

    Sarah Gillemot

  14. Synchronous diversification of Sulawesi's iconic artiodactyls driven by recent geological events

    Article • Proceedings of the Royal Society B Biological Sciences, April 2018, Royal Society Publishing

    Sarah Gillemot

  15. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra

    Article • Drug Resistance Updates, March 2018, Elsevier

    Sarah Gillemot

  16. The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase

    Article • The Journal of Infectious Diseases, November 2017, Oxford University Press (OUP)

    Sarah Gillemot

  17. A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing

    Article • Journal of Clinical Virology, November 2017, Elsevier

    Sarah Gillemot

  18. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase

    Article • Nucleic Acids Research, September 2016, Oxford University Press (OUP)

    Sarah Gillemot

  19. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Sarah Gillemot, Lieve Naesens

  20. Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient

    Article • Antiviral Research, August 2016, Elsevier

    Sarah Gillemot

  21. Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies

    Article • Journal of Clinical Virology, January 2014, Elsevier

    Sarah Gillemot

  22. Antiviral Drug-Resistance Typing Reveals Compartmentalization and Dynamics of Acyclovir-Resistant Herpes Simplex Virus Type-2 (HSV-2) in a Case of Neonatal Herpes

    Article • Journal of the Pediatric Infectious Diseases Society, August 2013, Oxford University Press (OUP)

    Sarah Gillemot

  23. Polymorphic microsatellite markers for the endangered golden-headed lion tamarin, Leontopithecus chrysomelas (Callitrichidae)

    Article • Conservation Genetics, August 2007, Springer Science + Business Media

    Sarah Gillemot

  24. Isolation of microsatellite markers for the endangered Knysna seahorseHippocampus capensisand their use in the detection of a genetic bottleneck

    Article • Molecular Ecology Notes, January 2007, Wiley

    Prof. Peter R Teske, Sarah Gillemot